We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Wednesday, April 09, 2025
The Trump administration plans to make vaccines a central part of its strategy to control bird flu, even as farm industry groups remain divided on whether that’s the best way to go.
A surge of highly pathogenic avian influenza cases in dairy cattle and the first death of a person from the virus have refocused attention on the ongoing outbreak, which shows no signs of fading away anytime soon.
A federal jury in Illinois has found two large egg producers and trade associations liable for conspiring to restrict supply and drive up egg prices, in a dispute the judge in the case said pitted “the nation’s egg makers against its egg breakers.”
The prospect of vaccinating against the spread of highly-pathogenic avian influenza has divided the nation's poultry industry groups as the Biden administration moves forward with plans to conduct vaccination trials this month.
Animal agriculture groups and USDA are concerned that EPA-proposed restrictions on rodenticides will increase costs for producers but not provide effective control of rats, mice, moles and other vermin.
Consumers can expect higher egg prices, egg producers will see lower profits, and retailers won't meet their promised timelines for transitioning to 100% cage-free, according to new research funded by the FMI Foundation, United Egg Producers and United Egg Association.
Poultry and egg producers are closely watching the spread of highly pathogenic avian influenza, which has already hit more states than the 2014-2015 outbreak and infected close to half the number of birds as it did seven years ago.
